UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls

PloS one, 2012-12, Vol.7 (12), p.e52285-e52285

2012

Volltextzugriff (PDF)

ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects

Journal of neuroinflammation, 2011-08, Vol.8 (1), p.93-93, Article 93

2011

Volltextzugriff (PDF)

Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein

International immunopharmacology, 2013-08, Vol.16 (4), p.424-428

2013

Volltextzugriff (PDF)

Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary report

Experimental gerontology, 2015-07, Vol.67, p.15-18

2015

Volltextzugriff (PDF)

Biophysical characterization data on Aβ soluble oligomers produced through a method enabling prolonged oligomer stability and biological buffer conditions

Data in brief, 2015-09, Vol.4 (C), p.650-658

2015

Volltextzugriff (PDF)

CSF Nrf2 and HSPA8 in Parkinson’s disease patients with and without LRRK2 gene mutations

Journal of Neural Transmission, 2016-03, Vol.123 (3), p.179-187

2016

Volltextzugriff (PDF)

Kinetic analysis of IgG antibodies to beta-amyloid oligomers with surface plasmon resonance

Analytical biochemistry, 2015-07, Vol.481, p.43-54

2015

Volltextzugriff (PDF)

Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies

Immunology letters, 2013-07, Vol.154 (1), p.7-11

2013

Volltextzugriff (PDF)

Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity

International immunopharmacology, 2012-12, Vol.14 (4), p.550-557

2012

Volltextzugriff (PDF)

Development of Antihuman IgG Antibodies and Hematologic Deficits but Not Clinical Abnormalities in C57BL/6 Mice after Repeated Administration of Human Intravenous Immunoglobulin

Comparative medicine, 2012-02, Vol.62 (1), p.31-36

2012

Volltextzugriff (PDF)

Synuclein and Anti-[alpha]-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

PloS one, 2012-12, Vol.7 (12), p.e52285

2012

Volltextzugriff (PDF)

ELISA measurement of specific non-antigen-bound antibodies to A[beta]1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects

Journal of neuroinflammation, 2011-08, Vol.8, p.93

2011

Volltextzugriff (PDF)

A phase I study of enfortumab vedotin (ASG-22CE; ASG-22ME): Updated analysis of patients with metastatic urothelial cancer

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.106-106

2017

Volltextzugriff (PDF)

Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4533-4533

2016

Volltextzugriff (PDF)

A statement on abortion by 100 professors of obstetrics: 40 years later

American journal of obstetrics and gynecology, 2013-09, Vol.209 (3), p.193-199

One Hundred Professors of Obstetrics and Gynecology

2013

Volltextzugriff (PDF)

Maintenance treatment of preterm labor with the oxytocin antagonist atosiban

American journal of obstetrics and gynecology, 2000-05, Vol.182 (5), p.1184-1190

2000

Volltextzugriff (PDF)

ASHP statement on criteria for an intermediate category of drug products

American journal of health-system pharmacy, 2009-03, Vol.66 (5), p.502-505

American Society of Health-System Pharmacists

2009

Volltextzugriff (PDF)

Advancing Space Science Requires NASA Support for Coordination Between the Science Mission Directorate Communities

Bulletin of the AAS, 2021-03, Vol.53 (4)

2021

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

α-Synuclein and anti-α-synuclein antibodies in Parkinson's disease, atypical Parkinson syndromes, REM sleep behavior disorder, and healthy controls

ELISA measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects

Intravenous immunoglobulin products contain specific antibodies to recombinant human tau protein

Effects of antibodies to phosphorylated and non-phosphorylated tau on in vitro tau phosphorylation at Serine-199: Preliminary report

Biophysical characterization data on Aβ soluble oligomers produced through a method enabling prolonged oligomer stability and biological buffer conditions

CSF Nrf2 and HSPA8 in Parkinson’s disease patients with and without LRRK2 gene mutations

Kinetic analysis of IgG antibodies to beta-amyloid oligomers with surface plasmon resonance

Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies

Effects of intravenous immunoglobulin on alpha synuclein aggregation and neurotoxicity

Development of Antihuman IgG Antibodies and Hematologic Deficits but Not Clinical Abnormalities in C57BL/6 Mice after Repeated Administration of Human Intravenous Immunoglobulin

Synuclein and Anti-[alpha]-Synuclein Antibodies in Parkinson's Disease, Atypical Parkinson Syndromes, REM Sleep Behavior Disorder, and Healthy Controls

ELISA measurement of specific non-antigen-bound antibodies to A[beta]1-42 monomer and soluble oligomers in sera from Alzheimer's disease, mild cognitively impaired, and noncognitively impaired subjects

A phase I study of enfortumab vedotin (ASG-22CE; ASG-22ME): Updated analysis of patients with metastatic urothelial cancer

Anti-tumor activity, safety and pharmacokinetics (PK) of ASG-22CE (ASG-22ME; enfortumab vedotin) in a phase I dose escalation trial in patients (Pts) with metastatic urothelial cancer (mUC)

A statement on abortion by 100 professors of obstetrics: 40 years later

Maintenance treatment of preterm labor with the oxytocin antagonist atosiban

ASHP statement on criteria for an intermediate category of drug products

Advancing Space Science Requires NASA Support for Coordination Between the Science Mission Directorate Communities

Suchergebnisse filtern